/
CRIS
$1.80+$0.20 (+11.98%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$3.5M
2M shares
52-week range
$1.54 – $39.00
1% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-2942.13
Curis Inc
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
www.curis.com- Employees
- 24
- IPO / List date
- Aug 1, 2000
- HQ
- LEXINGTON, MA
Held by traders on TradeandTell
No one on the platform currently holds CRIS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 240,917 | $237.8K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-07-06 | 1-for-20reverse |
| 2023-09-29 | 1-for-20reverse |
| 2018-05-30 | 1-for-5reverse |
Recent trades on TradeandTell
No one on the platform has traded CRIS yet.
